These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10439166)

  • 21. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
    Teknos TN; Rosenthal EL; Lee D; Taylor R; Marn CS
    Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
    Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
    Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
    Stoeckli SJ; Mosna-Firlejczyk K; Goerres GW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):411-6. PubMed ID: 12634970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
    Shintani SA; Foote RL; Lowe VJ; Brown PD; Garces YI; Kasperbauer JL
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):322-9. PubMed ID: 17889447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
    Sakamoto H; Nakai Y; Ohashi Y; Matsuda M; Sakashita T; Nasako Y; Kitayama H; Kawabe J; Okamura T; Ochi H
    Acta Otolaryngol Suppl; 1998; 538():254-60. PubMed ID: 9879431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
    Bohuslavizki KH; Klutmann S; Sonnemann U; Thoms J; Kröger S; Werner JA; Mester J; Clausen M
    Laryngorhinootologie; 1999 Aug; 78(8):445-9. PubMed ID: 10488465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.
    Périé S; Montravers F; Kerrou K; Angelard B; Tassart M; Talbot JN; Lacau St Guily J
    Ann Otol Rhinol Laryngol; 2002 Sep; 111(9):763-71. PubMed ID: 12296328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
    Vermeersch H; Loose D; Ham H; Otte A; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1689-700. PubMed ID: 14574516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
    Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
    Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
    Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
    Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
    Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
    Fogarty GB; Peters LJ; Stewart J; Scott C; Rischin D; Hicks RJ
    Head Neck; 2003 Feb; 25(2):138-45. PubMed ID: 12509797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography in the management of unknown primary head and neck carcinoma.
    Miller FR; Hussey D; Beeram M; Eng T; McGuff HS; Otto RA
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):626-9. PubMed ID: 16027287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
    Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
    Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
    Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
    Head Neck; 2005 Jun; 27(6):494-502. PubMed ID: 15772951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of [18F]-FDG PET-CT in the management of the head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Cammilleri S; Mundler O; Giovanni A; Zanaret M
    Bull Cancer; 2006 Oct; 93(10):1017-25. PubMed ID: 17074660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
    Paulus P; Sambon A; Vivegnis D; Hustinx R; Moreau P; Collignon J; Deneufbourg JM; Rigo P
    Laryngoscope; 1998 Oct; 108(10):1578-83. PubMed ID: 9778305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.